1.36
Finanzdaten der Tenax Therapeutics Inc-Aktie (TENX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
|
|
13.34%
18.78
|
16.57 | 16.45 | 16.81 | 11.79 |
| Operating Income/Loss |
13.34%
-18.78
|
-16.57 | -16.45 | -16.81 | -11.79 |
| Net Income/Loss |
13.28%
-17.80
|
-15.72 | -15.54 | -15.80 | -10.85 |
| Basic Average Shares |
12.48%
50.87
|
45.23 | 0.5728 | 39.74 | 39.57 |
| Diluted Average Shares |
12.48%
50.87
|
45.23 | 0.5728 | 39.74 | 39.57 |
| Basic Earnings Per Share |
0.00%
-0.35
|
-0.35 | -0.38 | -0.40 | -0.27 |
| Diluted Earnings Per Share |
0.00%
-0.35
|
-0.35 | -0.38 | -0.40 | -0.27 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):